000 01370 a2200397 4500
005 20250516024929.0
264 0 _c20110804
008 201108s 0 0 jpn d
022 _a0917-5857
024 7 _aCliCa1103429438
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaguchi, Tetsuya
245 0 0 _a[Encounter of cancer cells with bone. Treatment of bone metastases from breast cancer].
_h[electronic resource]
260 _bClinical calcium
_cMar 2011
300 _a429-38 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aBone Density Conservation Agents
_xpharmacology
650 0 4 _aBone Neoplasms
_xpathology
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aCombined Modality Therapy
650 0 4 _aDenosumab
650 0 4 _aDiphosphonates
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImidazoles
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aOsteoclasts
_xdrug effects
650 0 4 _aPamidronate
650 0 4 _aRANK Ligand
_xphysiology
650 0 4 _aStrontium
_xtherapeutic use
650 0 4 _aZoledronic Acid
773 0 _tClinical calcium
_gvol. 21
_gno. 3
_gp. 429-38
856 4 0 _uhttps://doi.org/CliCa1103429438
_zAvailable from publisher's website
999 _c20632993
_d20632993